August 29, 2018

Media

Media & events

news

FUJIFILM Joins Lyndra Therapeutics’ Series B Raise, Bringing Total Round to $60 Million

February 11, 2019
Lyndra Therapeutics announced that FUJIFILM has joined the company’s Series B raise, bringing the total round to $60 million Thanks...
Read More
1 3 4 5 6 7 13

publications

  • Lyndra White Paper on Adherence to Medication
    Lyndra White Paper on Adherence to Medication
1 3 4 5
Asset 2 (3)
Asset 2 (3)
Lyndra White Paper on Adherence to Medication

Lyndra White Paper on Adherence to Medication
2016-09-24

URL : View Project

awardS

Lyndra Named as Scrip Award Finalist in Two Categories

Happy to announce our ultra-long acting oral dosage form has been named a finalist for the Scrip MSD Innovation Award, and our co-founder Amy Schulman has been named a finalist in the Executive of the Year category!

#ScripAwards

Amy Schulman, Lyndra Co-founder and CEO, honored on 2019 PharmaVOICE 100

“Amy’s fearless approach to create durable value and change the trajectory of compliance for some of most difficult to treat diseases —  Alzheimer’s disease, HIV, opioid use disorder, and schizophrenia — are just a couple of the reasons she has been identified as one of the 100 most inspiring people in the life-sciences industry,” says Taren Grom, editor, PharmaVOICE

#PharmaVOICE

2019 Xconomy Awards Finalist in Startup Category

We are honored to be named a finalist for the Awards in the category for our work making daily pills a thing of the past.

#XconomyAwards

events

Lyndra Presents @ BIO International

Join us on Thursday, June 5th, at 5pm when Andrew Bellinger, our CSO, presents our 2019 Company Update at BIO International, Philadelphia Convention Center, Theater 4

2019 BIO International